nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—Progesterone—uterine cancer	0.145	0.222	CbGbCtD
Lomitapide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.131	0.201	CbGbCtD
Lomitapide—ABCB1—Dactinomycin—uterine cancer	0.115	0.176	CbGbCtD
Lomitapide—CYP3A4—Progesterone—uterine cancer	0.0868	0.133	CbGbCtD
Lomitapide—ABCB1—Etoposide—uterine cancer	0.0648	0.0994	CbGbCtD
Lomitapide—ABCB1—Doxorubicin—uterine cancer	0.0442	0.0678	CbGbCtD
Lomitapide—CYP3A4—Etoposide—uterine cancer	0.0388	0.0596	CbGbCtD
Lomitapide—CYP3A4—Doxorubicin—uterine cancer	0.0265	0.0406	CbGbCtD
Lomitapide—MTTP—renal system—uterine cancer	0.00575	0.268	CbGeAlD
Lomitapide—MTTP—female reproductive system—uterine cancer	0.00461	0.215	CbGeAlD
Lomitapide—MTTP—female gonad—uterine cancer	0.00419	0.195	CbGeAlD
Lomitapide—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.0032	CcSEcCtD
Lomitapide—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00319	CcSEcCtD
Lomitapide—Infection—Progesterone—uterine cancer	0.00104	0.00318	CcSEcCtD
Lomitapide—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00314	CcSEcCtD
Lomitapide—Nervous system disorder—Progesterone—uterine cancer	0.00102	0.00313	CcSEcCtD
Lomitapide—Skin disorder—Progesterone—uterine cancer	0.00101	0.0031	CcSEcCtD
Lomitapide—Rash erythematous—Doxorubicin—uterine cancer	0.00101	0.0031	CcSEcCtD
Lomitapide—Hyperhidrosis—Progesterone—uterine cancer	0.00101	0.00309	CcSEcCtD
Lomitapide—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000987	0.00302	CcSEcCtD
Lomitapide—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000987	0.00302	CcSEcCtD
Lomitapide—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000987	0.00302	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00098	0.003	CcSEcCtD
Lomitapide—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000975	0.00299	CcSEcCtD
Lomitapide—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000965	0.00296	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Etoposide—uterine cancer	0.000959	0.00293	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000951	0.00291	CcSEcCtD
Lomitapide—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00094	0.00288	CcSEcCtD
Lomitapide—Paraesthesia—Progesterone—uterine cancer	0.000938	0.00287	CcSEcCtD
Lomitapide—Chills—Dactinomycin—uterine cancer	0.000932	0.00285	CcSEcCtD
Lomitapide—Somnolence—Progesterone—uterine cancer	0.000928	0.00284	CcSEcCtD
Lomitapide—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000928	0.00284	CcSEcCtD
Lomitapide—Dyspepsia—Progesterone—uterine cancer	0.000919	0.00281	CcSEcCtD
Lomitapide—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000919	0.00281	CcSEcCtD
Lomitapide—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000915	0.0028	CcSEcCtD
Lomitapide—Decreased appetite—Progesterone—uterine cancer	0.000908	0.00278	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Progesterone—uterine cancer	0.000902	0.00276	CcSEcCtD
Lomitapide—Fatigue—Progesterone—uterine cancer	0.0009	0.00276	CcSEcCtD
Lomitapide—Constipation—Progesterone—uterine cancer	0.000893	0.00273	CcSEcCtD
Lomitapide—Blood bilirubin increased—Epirubicin—uterine cancer	0.000887	0.00272	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000862	0.00264	CcSEcCtD
Lomitapide—Feeling abnormal—Progesterone—uterine cancer	0.000861	0.00263	CcSEcCtD
Lomitapide—Gait disturbance—Epirubicin—uterine cancer	0.00086	0.00263	CcSEcCtD
Lomitapide—Gastrointestinal pain—Progesterone—uterine cancer	0.000854	0.00261	CcSEcCtD
Lomitapide—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00085	0.0026	CcSEcCtD
Lomitapide—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000841	0.00258	CcSEcCtD
Lomitapide—Ill-defined disorder—Dactinomycin—uterine cancer	0.000839	0.00257	CcSEcCtD
Lomitapide—Infestation NOS—Etoposide—uterine cancer	0.000838	0.00256	CcSEcCtD
Lomitapide—Infestation—Etoposide—uterine cancer	0.000838	0.00256	CcSEcCtD
Lomitapide—Anaemia—Dactinomycin—uterine cancer	0.000836	0.00256	CcSEcCtD
Lomitapide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000833	0.00255	CcSEcCtD
Lomitapide—Body temperature increased—Progesterone—uterine cancer	0.000825	0.00253	CcSEcCtD
Lomitapide—Abdominal pain—Progesterone—uterine cancer	0.000825	0.00253	CcSEcCtD
Lomitapide—Eructation—Epirubicin—uterine cancer	0.000825	0.00252	CcSEcCtD
Lomitapide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000823	0.00252	CcSEcCtD
Lomitapide—Blood bilirubin increased—Doxorubicin—uterine cancer	0.000821	0.00251	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000817	0.0025	CcSEcCtD
Lomitapide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000816	0.0025	CcSEcCtD
Lomitapide—Malaise—Dactinomycin—uterine cancer	0.000816	0.0025	CcSEcCtD
Lomitapide—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000809	0.00248	CcSEcCtD
Lomitapide—Gait disturbance—Doxorubicin—uterine cancer	0.000796	0.00244	CcSEcCtD
Lomitapide—Hepatobiliary disease—Etoposide—uterine cancer	0.000792	0.00242	CcSEcCtD
Lomitapide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00078	0.00239	CcSEcCtD
Lomitapide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000774	0.00237	CcSEcCtD
Lomitapide—Myalgia—Dactinomycin—uterine cancer	0.00077	0.00236	CcSEcCtD
Lomitapide—Eructation—Doxorubicin—uterine cancer	0.000763	0.00234	CcSEcCtD
Lomitapide—Discomfort—Dactinomycin—uterine cancer	0.000761	0.00233	CcSEcCtD
Lomitapide—Ecchymosis—Epirubicin—uterine cancer	0.000759	0.00232	CcSEcCtD
Lomitapide—Asthenia—Progesterone—uterine cancer	0.000749	0.00229	CcSEcCtD
Lomitapide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000748	0.00229	CcSEcCtD
Lomitapide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000748	0.00229	CcSEcCtD
Lomitapide—Urinary tract disorder—Etoposide—uterine cancer	0.000743	0.00227	CcSEcCtD
Lomitapide—Urethral disorder—Etoposide—uterine cancer	0.000737	0.00226	CcSEcCtD
Lomitapide—Infection—Dactinomycin—uterine cancer	0.000733	0.00224	CcSEcCtD
Lomitapide—CYP3A4—renal system—uterine cancer	0.000717	0.0334	CbGeAlD
Lomitapide—Diarrhoea—Progesterone—uterine cancer	0.000714	0.00219	CcSEcCtD
Lomitapide—Eye disorder—Etoposide—uterine cancer	0.000703	0.00215	CcSEcCtD
Lomitapide—Ecchymosis—Doxorubicin—uterine cancer	0.000702	0.00215	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.0007	0.00214	CcSEcCtD
Lomitapide—Cardiac disorder—Etoposide—uterine cancer	0.000698	0.00214	CcSEcCtD
Lomitapide—ABCB1—myometrium—uterine cancer	0.000697	0.0325	CbGeAlD
Lomitapide—Dizziness—Progesterone—uterine cancer	0.000691	0.00211	CcSEcCtD
Lomitapide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000679	0.00208	CcSEcCtD
Lomitapide—Mediastinal disorder—Etoposide—uterine cancer	0.000678	0.00207	CcSEcCtD
Lomitapide—Chills—Etoposide—uterine cancer	0.000675	0.00207	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000672	0.00206	CcSEcCtD
Lomitapide—Vomiting—Progesterone—uterine cancer	0.000664	0.00203	CcSEcCtD
Lomitapide—Headache—Progesterone—uterine cancer	0.000654	0.002	CcSEcCtD
Lomitapide—Increased appetite—Epirubicin—uterine cancer	0.000648	0.00198	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000648	0.00198	CcSEcCtD
Lomitapide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000647	0.00198	CcSEcCtD
Lomitapide—Decreased appetite—Dactinomycin—uterine cancer	0.000642	0.00196	CcSEcCtD
Lomitapide—Dermatitis bullous—Epirubicin—uterine cancer	0.000637	0.00195	CcSEcCtD
Lomitapide—Fatigue—Dactinomycin—uterine cancer	0.000636	0.00195	CcSEcCtD
Lomitapide—Back pain—Etoposide—uterine cancer	0.000633	0.00194	CcSEcCtD
Lomitapide—Muscle spasms—Etoposide—uterine cancer	0.000629	0.00193	CcSEcCtD
Lomitapide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000626	0.00192	CcSEcCtD
Lomitapide—Nausea—Progesterone—uterine cancer	0.00062	0.0019	CcSEcCtD
Lomitapide—Pain in extremity—Epirubicin—uterine cancer	0.000609	0.00186	CcSEcCtD
Lomitapide—Feeling abnormal—Dactinomycin—uterine cancer	0.000608	0.00186	CcSEcCtD
Lomitapide—Ill-defined disorder—Etoposide—uterine cancer	0.000607	0.00186	CcSEcCtD
Lomitapide—Anaemia—Etoposide—uterine cancer	0.000605	0.00185	CcSEcCtD
Lomitapide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000604	0.00185	CcSEcCtD
Lomitapide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000602	0.00184	CcSEcCtD
Lomitapide—Increased appetite—Doxorubicin—uterine cancer	0.0006	0.00184	CcSEcCtD
Lomitapide—Migraine—Epirubicin—uterine cancer	0.0006	0.00184	CcSEcCtD
Lomitapide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000593	0.00181	CcSEcCtD
Lomitapide—Malaise—Etoposide—uterine cancer	0.00059	0.00181	CcSEcCtD
Lomitapide—Dermatitis bullous—Doxorubicin—uterine cancer	0.00059	0.00181	CcSEcCtD
Lomitapide—Vertigo—Etoposide—uterine cancer	0.000588	0.0018	CcSEcCtD
Lomitapide—Abdominal pain—Dactinomycin—uterine cancer	0.000583	0.00179	CcSEcCtD
Lomitapide—Body temperature increased—Dactinomycin—uterine cancer	0.000583	0.00179	CcSEcCtD
Lomitapide—CYP3A4—female reproductive system—uterine cancer	0.000574	0.0268	CbGeAlD
Lomitapide—Dehydration—Epirubicin—uterine cancer	0.000567	0.00173	CcSEcCtD
Lomitapide—Pain in extremity—Doxorubicin—uterine cancer	0.000564	0.00173	CcSEcCtD
Lomitapide—Liver function test abnormal—Epirubicin—uterine cancer	0.000562	0.00172	CcSEcCtD
Lomitapide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000562	0.00172	CcSEcCtD
Lomitapide—Dry skin—Epirubicin—uterine cancer	0.000558	0.00171	CcSEcCtD
Lomitapide—Chest pain—Etoposide—uterine cancer	0.000557	0.00171	CcSEcCtD
Lomitapide—Abdominal pain upper—Epirubicin—uterine cancer	0.000556	0.0017	CcSEcCtD
Lomitapide—Migraine—Doxorubicin—uterine cancer	0.000555	0.0017	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000553	0.00169	CcSEcCtD
Lomitapide—Discomfort—Etoposide—uterine cancer	0.000551	0.00169	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000549	0.00168	CcSEcCtD
Lomitapide—ABCB1—epithelium—uterine cancer	0.000547	0.0255	CbGeAlD
Lomitapide—Nasopharyngitis—Epirubicin—uterine cancer	0.000545	0.00167	CcSEcCtD
Lomitapide—ABCB1—uterine cervix—uterine cancer	0.000543	0.0253	CbGeAlD
Lomitapide—Gastritis—Epirubicin—uterine cancer	0.000539	0.00165	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000537	0.00164	CcSEcCtD
Lomitapide—Infection—Etoposide—uterine cancer	0.000531	0.00162	CcSEcCtD
Lomitapide—Abdominal distension—Epirubicin—uterine cancer	0.00053	0.00162	CcSEcCtD
Lomitapide—Asthenia—Dactinomycin—uterine cancer	0.00053	0.00162	CcSEcCtD
Lomitapide—Influenza—Epirubicin—uterine cancer	0.000527	0.00161	CcSEcCtD
Lomitapide—Dehydration—Doxorubicin—uterine cancer	0.000524	0.0016	CcSEcCtD
Lomitapide—Liver function test abnormal—Doxorubicin—uterine cancer	0.00052	0.00159	CcSEcCtD
Lomitapide—Skin disorder—Etoposide—uterine cancer	0.000519	0.00159	CcSEcCtD
Lomitapide—ABCB1—decidua—uterine cancer	0.000517	0.0241	CbGeAlD
Lomitapide—Dry skin—Doxorubicin—uterine cancer	0.000517	0.00158	CcSEcCtD
Lomitapide—Hyperhidrosis—Etoposide—uterine cancer	0.000516	0.00158	CcSEcCtD
Lomitapide—Abdominal pain upper—Doxorubicin—uterine cancer	0.000515	0.00158	CcSEcCtD
Lomitapide—Angina pectoris—Epirubicin—uterine cancer	0.000513	0.00157	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000508	0.00155	CcSEcCtD
Lomitapide—ABCB1—renal system—uterine cancer	0.000508	0.0237	CbGeAlD
Lomitapide—Diarrhoea—Dactinomycin—uterine cancer	0.000505	0.00155	CcSEcCtD
Lomitapide—Nasopharyngitis—Doxorubicin—uterine cancer	0.000504	0.00154	CcSEcCtD
Lomitapide—Gastritis—Doxorubicin—uterine cancer	0.000499	0.00153	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000497	0.00152	CcSEcCtD
Lomitapide—ABCB1—endometrium—uterine cancer	0.000491	0.0229	CbGeAlD
Lomitapide—Abdominal distension—Doxorubicin—uterine cancer	0.00049	0.0015	CcSEcCtD
Lomitapide—Influenza—Doxorubicin—uterine cancer	0.000487	0.00149	CcSEcCtD
Lomitapide—Paraesthesia—Etoposide—uterine cancer	0.00048	0.00147	CcSEcCtD
Lomitapide—Weight decreased—Epirubicin—uterine cancer	0.000476	0.00146	CcSEcCtD
Lomitapide—Somnolence—Etoposide—uterine cancer	0.000475	0.00145	CcSEcCtD
Lomitapide—ABCB1—mammalian vulva—uterine cancer	0.000475	0.0221	CbGeAlD
Lomitapide—Angina pectoris—Doxorubicin—uterine cancer	0.000475	0.00145	CcSEcCtD
Lomitapide—Infestation NOS—Epirubicin—uterine cancer	0.000469	0.00144	CcSEcCtD
Lomitapide—Infestation—Epirubicin—uterine cancer	0.000469	0.00144	CcSEcCtD
Lomitapide—Vomiting—Dactinomycin—uterine cancer	0.000469	0.00144	CcSEcCtD
Lomitapide—Decreased appetite—Etoposide—uterine cancer	0.000464	0.00142	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Etoposide—uterine cancer	0.000461	0.00141	CcSEcCtD
Lomitapide—Fatigue—Etoposide—uterine cancer	0.000461	0.00141	CcSEcCtD
Lomitapide—Constipation—Etoposide—uterine cancer	0.000457	0.0014	CcSEcCtD
Lomitapide—ABCB1—uterus—uterine cancer	0.000452	0.0211	CbGeAlD
Lomitapide—Haematuria—Epirubicin—uterine cancer	0.000448	0.00137	CcSEcCtD
Lomitapide—Hepatobiliary disease—Epirubicin—uterine cancer	0.000444	0.00136	CcSEcCtD
Lomitapide—Weight decreased—Doxorubicin—uterine cancer	0.000441	0.00135	CcSEcCtD
Lomitapide—Sinusitis—Epirubicin—uterine cancer	0.00044	0.00135	CcSEcCtD
Lomitapide—Feeling abnormal—Etoposide—uterine cancer	0.00044	0.00135	CcSEcCtD
Lomitapide—Nausea—Dactinomycin—uterine cancer	0.000438	0.00134	CcSEcCtD
Lomitapide—Gastrointestinal pain—Etoposide—uterine cancer	0.000437	0.00134	CcSEcCtD
Lomitapide—Infestation NOS—Doxorubicin—uterine cancer	0.000434	0.00133	CcSEcCtD
Lomitapide—Infestation—Doxorubicin—uterine cancer	0.000434	0.00133	CcSEcCtD
Lomitapide—Body temperature increased—Etoposide—uterine cancer	0.000422	0.00129	CcSEcCtD
Lomitapide—Abdominal pain—Etoposide—uterine cancer	0.000422	0.00129	CcSEcCtD
Lomitapide—Urinary tract disorder—Epirubicin—uterine cancer	0.000416	0.00127	CcSEcCtD
Lomitapide—Haematuria—Doxorubicin—uterine cancer	0.000414	0.00127	CcSEcCtD
Lomitapide—Connective tissue disorder—Epirubicin—uterine cancer	0.000414	0.00127	CcSEcCtD
Lomitapide—Urethral disorder—Epirubicin—uterine cancer	0.000413	0.00126	CcSEcCtD
Lomitapide—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000411	0.00126	CcSEcCtD
Lomitapide—Sinusitis—Doxorubicin—uterine cancer	0.000408	0.00125	CcSEcCtD
Lomitapide—ABCB1—female reproductive system—uterine cancer	0.000407	0.019	CbGeAlD
Lomitapide—Eye disorder—Epirubicin—uterine cancer	0.000394	0.00121	CcSEcCtD
Lomitapide—Cardiac disorder—Epirubicin—uterine cancer	0.000391	0.0012	CcSEcCtD
Lomitapide—Urinary tract disorder—Doxorubicin—uterine cancer	0.000385	0.00118	CcSEcCtD
Lomitapide—Asthenia—Etoposide—uterine cancer	0.000383	0.00117	CcSEcCtD
Lomitapide—Connective tissue disorder—Doxorubicin—uterine cancer	0.000383	0.00117	CcSEcCtD
Lomitapide—Urethral disorder—Doxorubicin—uterine cancer	0.000382	0.00117	CcSEcCtD
Lomitapide—Mediastinal disorder—Epirubicin—uterine cancer	0.00038	0.00116	CcSEcCtD
Lomitapide—Chills—Epirubicin—uterine cancer	0.000378	0.00116	CcSEcCtD
Lomitapide—ABCB1—female gonad—uterine cancer	0.00037	0.0172	CbGeAlD
Lomitapide—ABCB1—vagina—uterine cancer	0.000368	0.0171	CbGeAlD
Lomitapide—Malnutrition—Epirubicin—uterine cancer	0.000367	0.00112	CcSEcCtD
Lomitapide—Diarrhoea—Etoposide—uterine cancer	0.000365	0.00112	CcSEcCtD
Lomitapide—Eye disorder—Doxorubicin—uterine cancer	0.000364	0.00112	CcSEcCtD
Lomitapide—Cardiac disorder—Doxorubicin—uterine cancer	0.000362	0.00111	CcSEcCtD
Lomitapide—Flatulence—Epirubicin—uterine cancer	0.000362	0.00111	CcSEcCtD
Lomitapide—Back pain—Epirubicin—uterine cancer	0.000355	0.00109	CcSEcCtD
Lomitapide—Dizziness—Etoposide—uterine cancer	0.000353	0.00108	CcSEcCtD
Lomitapide—Muscle spasms—Epirubicin—uterine cancer	0.000353	0.00108	CcSEcCtD
Lomitapide—Mediastinal disorder—Doxorubicin—uterine cancer	0.000351	0.00108	CcSEcCtD
Lomitapide—Chills—Doxorubicin—uterine cancer	0.00035	0.00107	CcSEcCtD
Lomitapide—Ill-defined disorder—Epirubicin—uterine cancer	0.00034	0.00104	CcSEcCtD
Lomitapide—Vomiting—Etoposide—uterine cancer	0.00034	0.00104	CcSEcCtD
Lomitapide—Malnutrition—Doxorubicin—uterine cancer	0.000339	0.00104	CcSEcCtD
Lomitapide—Anaemia—Epirubicin—uterine cancer	0.000339	0.00104	CcSEcCtD
Lomitapide—Headache—Etoposide—uterine cancer	0.000335	0.00102	CcSEcCtD
Lomitapide—Flatulence—Doxorubicin—uterine cancer	0.000335	0.00102	CcSEcCtD
Lomitapide—Malaise—Epirubicin—uterine cancer	0.000331	0.00101	CcSEcCtD
Lomitapide—Vertigo—Epirubicin—uterine cancer	0.00033	0.00101	CcSEcCtD
Lomitapide—Back pain—Doxorubicin—uterine cancer	0.000328	0.00101	CcSEcCtD
Lomitapide—Muscle spasms—Doxorubicin—uterine cancer	0.000326	0.000999	CcSEcCtD
Lomitapide—Palpitations—Epirubicin—uterine cancer	0.000324	0.000993	CcSEcCtD
Lomitapide—Nausea—Etoposide—uterine cancer	0.000317	0.000971	CcSEcCtD
Lomitapide—Ill-defined disorder—Doxorubicin—uterine cancer	0.000315	0.000964	CcSEcCtD
Lomitapide—Anaemia—Doxorubicin—uterine cancer	0.000314	0.00096	CcSEcCtD
Lomitapide—Chest pain—Epirubicin—uterine cancer	0.000312	0.000956	CcSEcCtD
Lomitapide—Myalgia—Epirubicin—uterine cancer	0.000312	0.000956	CcSEcCtD
Lomitapide—Arthralgia—Epirubicin—uterine cancer	0.000312	0.000956	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00031	0.00095	CcSEcCtD
Lomitapide—Discomfort—Epirubicin—uterine cancer	0.000309	0.000945	CcSEcCtD
Lomitapide—Malaise—Doxorubicin—uterine cancer	0.000306	0.000937	CcSEcCtD
Lomitapide—Dry mouth—Epirubicin—uterine cancer	0.000305	0.000935	CcSEcCtD
Lomitapide—Vertigo—Doxorubicin—uterine cancer	0.000305	0.000934	CcSEcCtD
Lomitapide—Palpitations—Doxorubicin—uterine cancer	0.0003	0.000918	CcSEcCtD
Lomitapide—Infection—Epirubicin—uterine cancer	0.000297	0.000911	CcSEcCtD
Lomitapide—Nervous system disorder—Epirubicin—uterine cancer	0.000294	0.000899	CcSEcCtD
Lomitapide—Skin disorder—Epirubicin—uterine cancer	0.000291	0.00089	CcSEcCtD
Lomitapide—Hyperhidrosis—Epirubicin—uterine cancer	0.000289	0.000886	CcSEcCtD
Lomitapide—Arthralgia—Doxorubicin—uterine cancer	0.000289	0.000885	CcSEcCtD
Lomitapide—Chest pain—Doxorubicin—uterine cancer	0.000289	0.000885	CcSEcCtD
Lomitapide—Myalgia—Doxorubicin—uterine cancer	0.000289	0.000885	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000287	0.000879	CcSEcCtD
Lomitapide—Discomfort—Doxorubicin—uterine cancer	0.000286	0.000874	CcSEcCtD
Lomitapide—Dry mouth—Doxorubicin—uterine cancer	0.000283	0.000865	CcSEcCtD
Lomitapide—Infection—Doxorubicin—uterine cancer	0.000275	0.000843	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000273	0.000835	CcSEcCtD
Lomitapide—Nervous system disorder—Doxorubicin—uterine cancer	0.000272	0.000832	CcSEcCtD
Lomitapide—Skin disorder—Doxorubicin—uterine cancer	0.000269	0.000824	CcSEcCtD
Lomitapide—Paraesthesia—Epirubicin—uterine cancer	0.000269	0.000823	CcSEcCtD
Lomitapide—Hyperhidrosis—Doxorubicin—uterine cancer	0.000268	0.00082	CcSEcCtD
Lomitapide—Somnolence—Epirubicin—uterine cancer	0.000266	0.000815	CcSEcCtD
Lomitapide—Dyspepsia—Epirubicin—uterine cancer	0.000264	0.000807	CcSEcCtD
Lomitapide—Decreased appetite—Epirubicin—uterine cancer	0.00026	0.000797	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000259	0.000791	CcSEcCtD
Lomitapide—Fatigue—Epirubicin—uterine cancer	0.000258	0.00079	CcSEcCtD
Lomitapide—Constipation—Epirubicin—uterine cancer	0.000256	0.000784	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000252	0.000773	CcSEcCtD
Lomitapide—Paraesthesia—Doxorubicin—uterine cancer	0.000249	0.000762	CcSEcCtD
Lomitapide—Feeling abnormal—Epirubicin—uterine cancer	0.000247	0.000755	CcSEcCtD
Lomitapide—Somnolence—Doxorubicin—uterine cancer	0.000246	0.000754	CcSEcCtD
Lomitapide—Gastrointestinal pain—Epirubicin—uterine cancer	0.000245	0.00075	CcSEcCtD
Lomitapide—Dyspepsia—Doxorubicin—uterine cancer	0.000244	0.000747	CcSEcCtD
Lomitapide—Decreased appetite—Doxorubicin—uterine cancer	0.000241	0.000737	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000239	0.000732	CcSEcCtD
Lomitapide—Fatigue—Doxorubicin—uterine cancer	0.000239	0.000731	CcSEcCtD
Lomitapide—ABCB1—lymph node—uterine cancer	0.000238	0.0111	CbGeAlD
Lomitapide—Constipation—Doxorubicin—uterine cancer	0.000237	0.000725	CcSEcCtD
Lomitapide—Abdominal pain—Epirubicin—uterine cancer	0.000237	0.000725	CcSEcCtD
Lomitapide—Body temperature increased—Epirubicin—uterine cancer	0.000237	0.000725	CcSEcCtD
Lomitapide—Feeling abnormal—Doxorubicin—uterine cancer	0.000228	0.000699	CcSEcCtD
Lomitapide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000227	0.000694	CcSEcCtD
Lomitapide—Abdominal pain—Doxorubicin—uterine cancer	0.000219	0.00067	CcSEcCtD
Lomitapide—Body temperature increased—Doxorubicin—uterine cancer	0.000219	0.00067	CcSEcCtD
Lomitapide—Asthenia—Epirubicin—uterine cancer	0.000215	0.000658	CcSEcCtD
Lomitapide—Diarrhoea—Epirubicin—uterine cancer	0.000205	0.000627	CcSEcCtD
Lomitapide—Asthenia—Doxorubicin—uterine cancer	0.000199	0.000609	CcSEcCtD
Lomitapide—Dizziness—Epirubicin—uterine cancer	0.000198	0.000606	CcSEcCtD
Lomitapide—Vomiting—Epirubicin—uterine cancer	0.00019	0.000583	CcSEcCtD
Lomitapide—Diarrhoea—Doxorubicin—uterine cancer	0.00019	0.00058	CcSEcCtD
Lomitapide—Headache—Epirubicin—uterine cancer	0.000188	0.000574	CcSEcCtD
Lomitapide—Dizziness—Doxorubicin—uterine cancer	0.000183	0.000561	CcSEcCtD
Lomitapide—Nausea—Epirubicin—uterine cancer	0.000178	0.000544	CcSEcCtD
Lomitapide—Vomiting—Doxorubicin—uterine cancer	0.000176	0.000539	CcSEcCtD
Lomitapide—Headache—Doxorubicin—uterine cancer	0.000174	0.000531	CcSEcCtD
Lomitapide—Nausea—Doxorubicin—uterine cancer	0.000165	0.000504	CcSEcCtD
